XML 63 R53.htm IDEA: XBRL DOCUMENT v3.25.4
Acquisitions - Fair Value of Net Assets Acquired (Detail) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Line Items]      
Goodwill $ 1,114,408 $ 1,030,995 $ 987,120
908 Devices Inc. Bioprocessing Analytics Portfolio      
Business Combination [Line Items]      
Cash and cash equivalents 191    
Accounts receivable 1,110    
Inventory 6,946    
Prepaid expenses and other current assets 651    
Property and equipment 1,698    
Operating lease right of use asset 2,552    
Other noncurrent assets, long-term 41    
Goodwill 50,177    
Accounts payable (208)    
Accrued liabilities (542)    
Operating lease liabilities (2,552)    
Deferred revenue (2,366)    
Deferred tax liability (1,011)    
Fair value of net assets acquired 70,297    
908 Devices Inc. Bioprocessing Analytics Portfolio | Customer relationships      
Business Combination [Line Items]      
Intangible assets 5,040    
908 Devices Inc. Bioprocessing Analytics Portfolio | Developed Technology      
Business Combination [Line Items]      
Intangible assets 6,910    
908 Devices Inc. Bioprocessing Analytics Portfolio | Trademark and tradename      
Business Combination [Line Items]      
Intangible assets 1,660    
Tantti Laboratory Inc.      
Business Combination [Line Items]      
Cash and cash equivalents 85    
Accounts receivable 1    
Inventory 41    
Prepaid expenses and other current assets 321    
Property and equipment 731    
Operating lease right of use asset 637    
Other noncurrent assets, long-term 81    
Goodwill 46,943 46,900  
Accounts payable (18)    
Accrued liabilities (510)    
Operating lease liabilities (627)    
Deferred tax liability (1,515)    
Fair value of net assets acquired 75,080    
Tantti Laboratory Inc. | Developed Technology      
Business Combination [Line Items]      
Intangible assets 28,910 $ 28,900  
Metenova Holding AB      
Business Combination [Line Items]      
Cash and cash equivalents 5,768    
Accounts receivable 3,730    
Inventory 4,477    
Prepaid expenses and other current assets 470    
Property and equipment 433    
Operating lease right of use asset 615    
Goodwill 115,722   115,700
Accounts payable (1,432)    
Accrued liabilities (2,934)    
Operating lease liabilities (275)    
Deferred tax liability (12,481)    
Noncurrent operating lease liability (255)    
Fair value of net assets acquired 172,600    
Metenova Holding AB | Customer relationships      
Business Combination [Line Items]      
Intangible assets 12,659    
Metenova Holding AB | Developed Technology      
Business Combination [Line Items]      
Intangible assets 44,377    
Metenova Holding AB | Trademark and tradename      
Business Combination [Line Items]      
Intangible assets 939    
Metenova Holding AB | Non-compete agreements      
Business Combination [Line Items]      
Intangible assets 787    
FlexBiosys, Inc.      
Business Combination [Line Items]      
Cash and cash equivalents 1,090    
Accounts receivable 683    
Inventory 667    
Prepaid expenses and other current assets 35    
Property and equipment 12,034    
Operating lease right of use asset 3,537    
Other noncurrent assets, long-term 10    
Goodwill 14,321   $ 14,300
Accounts payable (136)    
Accrued liabilities (314)    
Operating lease liabilities (39)    
Noncurrent operating lease liability (3,498)    
Fair value of net assets acquired 41,030    
FlexBiosys, Inc. | Customer relationships      
Business Combination [Line Items]      
Intangible assets 2,530    
FlexBiosys, Inc. | Developed Technology      
Business Combination [Line Items]      
Intangible assets 9,860    
FlexBiosys, Inc. | Trademark and tradename      
Business Combination [Line Items]      
Intangible assets 30    
FlexBiosys, Inc. | Non-compete agreements      
Business Combination [Line Items]      
Intangible assets $ 220